chrisvoncsefalvay/vaers-outcomes huggingface dataset:
injection site, it was itchy and red; rash on her left arm, at the injection site; injection site, it was itchy and red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site, it was itchy and red), VACCINATION SITE RASH (rash on her left arm, at the injection site) and VACCINATION SITE ERYTHEMA (injection site, it was itchy and red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site, it was itchy and red), VACCINATION SITE RASH (rash on her left arm, at the injection site) and VACCINATION SITE ERYTHEMA (injection site, it was itchy and red). On 29-Jan-2021, VACCINATION SITE PRURITUS (injection site, it was itchy and red), VACCINATION SITE RASH (rash on her left arm, at the injection site) and VACCINATION SITE ERYTHEMA (injection site, it was itchy and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was taken. No treatment medication was taken.
After taking the 1 shot of the Vaccine I developed very loud ringing of the both ears with a 10,000 Hz frequency.  The ring has not stopped since getting the 1 st shot . I saw my Primary doctor and did all my blood work wand checkup and everything came back normal and refereed me to   a ENT doctor Facility.  He said everything look normal  and said it must be the Vaccine that caused the Tinnitus.
Patient is 6 years old. Fully vaccinated on 14Dec2021. Confirmed COVID positive on 06Jan2022; Patient is 6 years old. Fully vaccinated on 14Dec2021. Confirmed COVID positive on 06Jan2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 6 year-old patient received bnt162b2 (BNT162B2), administration date 14Dec2021 (Batch/Lot number: unknown) as dose 2 (tris), single and (Batch/Lot number: unknown) as dose 1 (tris), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 06Jan2022, outcome "unknown" and all described as "Patient is 6 years old. Fully vaccinated on 14Dec2021. Confirmed COVID positive on 06Jan2022". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (06Jan2022) positive.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
3/11-3/12/21 - heart palpitations, start of flu symptoms 3/13-3/18/21 - heart palpitations and high heart rate, blood pressure high and low, chills, weak, diarrhea, nausea, headache 3/19-3/23/21 - heart issues better, still had flu symptoms Propanolol and Alprazolam for heart palpitations.   ER visit 3/16 - recv IV's, all labs normal.  PCP visit 3/23.
5 days after second booster dose, my temperature suddenly went up to 100.2 degrees with severe lower back pain and pain down both legs.  Sore throat and cough also began during back spasms.  Fever has continued for the past 2 days, now coughing up green sputum, back pain not as severe but persists.  I emailed my doctor?s office to alert them.  I took an at home Covid test on 6/21/22?negative results.  I took another Covid test at the pharmacy today?PCR, waiting on results.
I had a lot of phlegm, cough but no fever and felt very fatigue. The phlegm was hard to swallow and had trouble sleeping.  My symptoms lasted for over a month. I took a COVID-19 Test on 01/18/2023 and it was positive. I was prescribed Azithromycin and I also had a Promethazine DM cough medicine I took.  I have recovered from my symptoms.
After the patient received her second COVID vaccine she stated that she felt dizzy. Student pharmacist alerted pharmacist, who immediately went to evaluate the patient. Patient then stated her throat was itchy. Pharmacist made the decision to administer IM epipen per protocol. Patient was then wheeled to the ER for further evaulation.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 01-DEC-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (Vls 10 SDV) (Lot # K007822, expiration date 15-AUG-2016) dose, route and anatomical location were not provided. There was no concomitant medication provided. On an unknown date, the PNEUMOVAX had a temperature excursion for 2112 hours, the highest recorded temperature was 59.9 F (15.5 Celsius). The vaccine status was reported as "in excursion", and was storage in a Refrigerator (R). There was no product quality complaint involved and no adverse effects were reported. This is one of several cases received from the same reporter. Additional information has been requested.
c/o not feeling well @ 7PM on the day vax recvd had been given APAP earlier in the day; lt arm tender, no fever; sleep through the noc; 630AM the following day c/o not feeling well some vomiting x 2; some tenderness below site, sl swelling;
Temp 101 & tonic/clonic seizure occuring on 7/21/97; 10 days after receiving MMR vax. Pt also had mild lymphadenopathy, measle-like rash which dvlped on 7/22/97. He has had reoccuring seizures since that time. 60 Day FU indicates seizure disorder, speech problem, change in his disposition (behavioral changes). Annual FU states same as 60 day and has sensory integration dysfunction, fine/gross motor incoordination; also states antiseize meds causes him to have a lot of "bad" side effects. Medical record states he has not had a fever but he has had a viral upper respiratory infection as of late. He has had 2 previous seizures, one accounted for by an MMR vax and a 2nd one which was approx 6 months ago and was blamed on a fever. Pt's workup had been negative to date, including neg EEG and CAT scan. He has only had a runny nose and slight cough but no other complaints. He seized for approx 25 minutes and was actively seizing on arrival to hosp.
received the adult dose; received the adult dose; This case was reported by a other health professional via call center representative and described the occurrence of accidental overdose in a 11-year-old female patient who received HBV (Engerix B adult) (batch number p4dj5, expiry date 15th December 2022) for prophylaxis.   On 21st September 2021, the patient received the 3rd dose of Engerix B adult (intramuscular). On 21st September 2021, unknown after receiving Engerix B adult, the patient experienced accidental overdose and adult product administered to child. On an unknown date, the outcome of the accidental overdose and adult product administered to child were unknown.  Additional details were reported as follows: The age at vaccination was not reported. A healthcare provider reported that a patient inadvertently received the adult dose of Engerix-B in the left deltoid which led to product administered to child and accidental overdose. The consented to follow up. The case had been linked with US2021199872 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021199872:Same reporter
Information has been received from a nurse concerning an unspecified number of patients of unknown age and gender. No concurrent or historical conditions were reported. Since unknown dates from 06-OCT-2015, the patients were inadvertently administered with improperly stored doses of GARDASIL 9 (lot # L013429, expiration date 21-JUL-2017, strength, dose and route unknown). No adverse effect had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
When preparing the vial, the 1.6mLs of diluent (Sodium Chloride)was mixed instead of 1.3mLs. The vaccine given was slightly weaker due to too much diluent mixed.
Patient had muscular pain and aching at the site of the injection after receiving the SHINGRIX vaccine on February 6th. On February 8th, she described having worsening soreness, stiffness, and muscular pains/aches in her shoulder, arm, neck, and throughout her back. The pain escalated and started to involve a shooting pain on February 11th and 12th. Patient stated that the pain is constant--about a 3 or 4 out of 10. The pain gets worse to an 8 out of 10 at times--both provoked and unprovoked. Her pain worsens if she lays on her left side or in certain positions, such as bending over to pick something up off the ground. Other times the pain worsens with no apparent cause. Patient has tried to take ibuprofen, naproxen, and a leftover opioid medication with little to no improvement in pain. Her doctor prescribed her amitriptyline on the 18th, which also did not help. On the 25th she was prescribed gabapentin and has not had relief with this medication yet (she is still currently taking). She is scheduled to see an ortho hand specialist on March 7th.
BODY ACHES; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, headache, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea, and had not recovered from body aches, and headache. This report was non-serious.
patient describes red rash beginning 2 days after immunization and skin peeling approximately 1 week after injection
Patient had a hard warm area that was sore to the touch on same arm as vaccines given w/ a fever of multiple days and a complaint of general malaise.
muscle aches; joint aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle aches) and ARTHRALGIA (joint aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle aches) and ARTHRALGIA (joint aches). At the time of the report, MYALGIA (muscle aches) and ARTHRALGIA (joint aches) outcome was unknown.
rash, raised, hot, red; rash; raised, hot, red; rash; raised, hot, red; rash; raised, hot, red; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (rash; raised, hot, red), ERYTHEMA (rash; raised, hot, red), RASH PAPULAR (rash, raised, hot, red) and RASH (rash; raised, hot, red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced FEELING HOT (rash; raised, hot, red), ERYTHEMA (rash; raised, hot, red) and RASH (rash; raised, hot, red). On an unknown date, the patient experienced RASH PAPULAR (rash, raised, hot, red). At the time of the report, FEELING HOT (rash; raised, hot, red), ERYTHEMA (rash; raised, hot, red), RASH PAPULAR (rash, raised, hot, red) and RASH (rash; raised, hot, red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.
This spontaneous report as received from a medical assistant refers to a 7 month old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 05-NOV-2018, the patient was vaccinated with improperly stored dose of ROTATEQ 2 ml tube, orally (lot # R007988, expiry date: 16-OCT-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) and time frame was 3.5 hours from 06-SEP-2018. Previous excursion was 50.37 °F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source.; Sender's Comments: US-009507513-1809USA002868: Original Case : 1809USA002868 US-009507513-1902USA009324: Original Case : 1902USA009323 US-009507513-1902USA009325: Original Case : 1902USA009323 US-009507513-1902USA009323: Original Case : 1902USA009323.
pt on CPAP/BiPAP at home for COPD; pt to ED via EMS for increasing SOB; O2 saturation 75% on CPAP; tachycardia; tachpneic; respiratory distress; tested positive for COVID; given remdesivir and steroids; respiratory status worsened requiring intubation; pneumothorax; asystole, no pulse; ACLS performed; pt passed away in the hospital
The shot was administered with no effect. It was not a problem until about 2 hours later. I could barely lift my arm due to the severe soreness in my arm. I wasn?t concerned. 04/07/21, then 04/08/21 upon awaking, arm was excruciatingly sore, itches on torso, and sore on left side of left breast. Very sore. My lymph nodes along my right jaw were extremely tender to the touch and swollen. I had a headache and fever. I took aspirin and went back to bed. Extremely fatigued throughout the day. What I really began to notice was a familiar feeling I had been hospitalized for in February. The hospital diagnosed me with rabdomylosis after being extremely sick for about 10 days with congestion, sore throat, cough, no fever, extreme fatigue, coughing, so so sick. I took a nap when I was feeling so much better and awoke to a stiff neck and the feeling of my upper extremities beginning to hurt like they had been bruised - like I?d fallen down the stairs. It spread quickly to my back, sides, ribs, stomach, you couldn?t touch me without it hurting like I was severely bruised. The urgent care sent me to the ER to test for  SM.  On 04/08 I began to feel that same exact soreness on my back, lower back, ribs, and my arm was extremely sore. I realized I must have had Covid back then.  My left ear began to itch severely 04/08, in the afternoon. I thought something had bitten my ear or that I?d maybe gotten poison oak. It got increasingly worse 04/09, and spread to the left of my scalp and back of my neck and right ear. As of today, I am itching on my back, chest, ears, head, and neck, and it?s starting to itch on my arms. The fatigue is not improving. I?m so tired. Because I?ve had congestion the entire time I have been in another state and coughing, I cannot tell if the scratchy throat is from that or the vaccine. But the itching is miserable.
Tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 04Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: FATIGUE (non-serious) with onset Mar2021, outcome "unknown", described as "Tiredness".  Additional information: The patient wanted to know the side effect of tiredness and how long will it last? The patient had been feeling very tired and wanted to know how long he can go like this. Other Products, Patient History and Investigation Assessment were Not Provided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Delayed Cutaneous Hypersensitivity aka COVID Arm -Day 6: Spotty red rash clusters around injection site (left arm) -Day 7: Spotty red rash clusters around injection site (left arm) -Day 8 (post-injection) solid red raised rash, approx. 3.5 inches in length, hot to the touch, firm to the touch
Caller states they are pregnant and received the GARDASIL vaccine; This spontaneous prospective pregnancy report was received from a female patient of unknown age and refers to herself. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.   On 09-DEC-2021, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) one dose, (lot #, expiration date, site and route of administration were not reported) for prophylaxis (exposure during pregnancy). The date of Last Menstrual Period (LMP) and due date were unknown. The pregnancy outcome was pending.  The outcome of the event is unknown.
Patient presented to urgent care after receiving vaccine approximately 24hrs prior with hives, burning skin sensation, flu-like symptoms.
Swollen arm after my second shot; Red arm; Hurts arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm after my second shot), ERYTHEMA (Red arm) and MYALGIA (Hurts arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm after my second shot), ERYTHEMA (Red arm) and MYALGIA (Hurts arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm after my second shot), ERYTHEMA (Red arm) and MYALGIA (Hurts arm) outcome was unknown. Not Provided          No concomitant medication was reported. Treatment medication was not provided.
Pt vaccinated with DTP/OPV found dead 4 days after receiving vac.  Infant apnea syndrome on monitor.
The patient came into the pharmacy and received a flu shot. After giving the shot, I turned to place the syringe in the sharps conainer. When I turned back around the patient looked faint, so I called out to her to see if she was ok. The patient was not responsive and then proceeded to pass out slouching onto her right shoulder in the chair. I called to the patient with no response. Shortly after passing out the patient began to have a tonic seizure-like reaction. She became rigid and stiff, clinching her teeth and struggling to breath. I immediately told my technician to call 911. The seizure lasted about 30 seconds to a minute. While seizing, I stabilized the patients head and neck and tried to maintin their airway. Breathing was taxed, however, the patient never stopped breathing. During the seizure the patient also urinated involuntarily. The patient regained consciousness and I ask her if she knew what happened and if she was feeling ok. The patient felt pale, faint, and nauseous. She was very out of it, but was responsive and able to answer questions correctly. Her blood pressure was 103/55 mmHg and heart rate was 72. EMS arrived and were briefed on the situation and the patient was taken to the hospital.
Severe itchiness and rashes all over body and face. Tiny bumps at the site of rashes. The symptoms come and go randomly throughout the day/night.
Patient felt dizzy 10 minutes after receiving the 2nd dose of Moderna, Alcohol was given to her to smell and to drink water and to remain relaxed and wait another 30 minutes and afterward she felt better. Patient did not want the ambulance called.
Pain when resting & walking, hot to touch, raised welts, redness, spread on 4th day over 5inches, began to turn purple.
Described aching joints that began on 5/5/00. Reported to provider on 5/12/00 with swelling in joints of hands, particularly (R).
Pfizer-BioNTech COVID-19 Vaccine EUA  Shaky and slightly dizzy Slight weakness and lightheadedness Began about two hours after receiving injection, and lasted the rest of the day
I had my second shingle shot at Pharmacy on June 25 2018 and the pharmacist applied a band aid first and gave the injection to me with band aid on. That afternoon I was not feeling well and didn't do much because the pain was severe. The soreness which I also had with the first shot on 4/21/2018 so I didn't think much about it. The next day, I felt weak, clammy, and dizzy. I immediately laid down on bed till the dizziness went away. I put ice on the site to help with pain. On the 20th of June, I went to take my bath and had a really red site where I had my shot. I took some pictures if needed and can mail them to you.
Patient received vaccine at 1:45pm, at 2:15pm complained of numbness and tingling of lips, edema of lips noted. No complaints of shortness of breath, chest pain, no pruritus or hives noted. Benadryl 50 mg elixir given. To ER via 911. Per Patient, treated in ER with steroids. Sent home with steroids, Benadryl and Epi pen.
Case number PHEH2014US025082, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 63-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Received the first shot; I currently have Covid; Received the first shot; I currently have Covid; This is a spontaneous report from a contactable consumer, the patient. A patient of an unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number unknown), via an unspecified route of administration on 24Jan2021 as a single dose for COVID-19 immunisation.  Medical history and concomitant medications were not reported.  The patient reported they received the first dose and they now currently have COVID. The patient stated they were to receive the second dose on 14Feb2021 and they contracted COVID and currently have COVID and they do not feel well. The patient inquired if they can still get the second dose if they still have COVID and if not, how long do they have to wait to get the second shot or do they have to start the whole series over again. The clinical outcome of the patient had COVID after the 1st dose of the vaccine was unknown.    The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.
presented to ED with complaints of fever, malaise and nausea since 8/29. received 2nd dose of hpv vaccine on 8/28. had no adverse reactions to first vaccine.history of seasonal allergies and yeast allergy.  Fever, malaise, nausea, sore throat.
one week after vaccine  noted red spot 2 inches below injection site  sl itch note.  Two weeks after vaccine was red to elbow and was not feeling well, itching was worse, went to Urgent Care saw Doctor  who order Preisone  and K-flex
Information has been received from a consumer who on 05-MAY-2008 was vaccinated with the third dose of GARDASIL vaccine (yeast) (Lot number not reported) and experienced flu like symptoms. Consumer declined to provide any additional information. No further information is available.
Follow up: Patient received casirivimab instead of intended COVID vaccine.  48-hr follow up didn't identify AEs. Patient Patient received COVID vaccine on December 31
Moderate, local reaction DTAP right deltoid area 1.5x12cm redness.